Unity Biotechnology , Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA.
18% short interest
Average analysts price target $21.00 | BUY
18% short interest
Average analysts price target $21.00 | BUY